Provided is a particle material that achieves excellent mechanical properties and optical properties when dispersed in a transparent resin material in order to solve the problem. In a case where primary particles having particle sizes in a certain range are formed into an aggregate, mechanical properties are enhanced while optical properties are maintained. The primary particles each have compositions different between the inside thereof and the surface thereof. Therefore, the optical properties to be obtained are easily controlled unlike an inorganic substance in which both of the compositions are mixed at an atomic level. The particle material of the present invention is an aggregate including primary particles in which a specific surface area. diameter is not less than 0.8 nm and not greater than 80 nm, the primary particles formed of an inorganic substance in which a composition of a surface and a composition of an inside are different.

A dental resin composite material is provided that is reduced in darkness of its color tone, and also reduced in burning and color unevenness. Specifically provided are a dental resin composite material including 100 parts by mass of a polyaryletherketone resin, 10 parts by mass to 300 parts by mass of inorganic particles, and 90 ppm or less of an impurity having an aromatic ring, a method of producing the dental resin composite material, and a polyaryletherketone resin for producing a dental resin composite material, to be used for producing the dental resin composite material.

A dental resin composite material is provided that is reduced in darkness of its color tone, and also reduced in burning and color unevenness. Specifically provided are a dental resin composite material including 100 parts by mass of a polyaryletherketone resin, 10 parts by mass to 300 parts by mass of inorganic particles, and 90 ppm or less of an impurity having an aromatic ring, a method of producing the dental resin composite material, and a polyaryletherketone resin for producing a dental resin composite material, to be used for producing the dental resin composite material.

A dental polymerizable composition including a glass powder and a (meth)acrylate is provided. The glass powder includes zinc, silicon, and fluorine and is substantially free of aluminum.

A dental polymerizable composition including a glass powder and a (meth)acrylate is provided. The glass powder includes zinc, silicon, and fluorine and is substantially free of aluminum.

The invention relates to the field of medicine and medical technology, namely to bone implants, and can be used in surgery, orthopedics, dentistry. Bone implants made of dense tough fibrous or fine-crystal silicate mineral aggregate or rock, jade, have high strength, resistance to crack formation, biological compatibility and the ability to integrate into bone tissue. The technical resultexpanding the field of medical devices for implantation into bone tissue.

The invention relates to the field of medicine and medical technology, namely to bone implants, and can be used in surgery, orthopedics, dentistry. Bone implants made of dense tough fibrous or fine-crystal silicate mineral aggregate or rock, jade, have high strength, resistance to crack formation, biological compatibility and the ability to integrate into bone tissue. The technical resultexpanding the field of medical devices for implantation into bone tissue.

An embodiment of the present invention, in a dental glass powder, contains zinc, silicon, fluorine and silver, and does not substantially contain aluminum.

The present invention relates to pharmaceutical compositions and methods for the treatment of peri-implant diseases, in particular peri-implant disease characterized by the destruction of the crest of the alveolar bone supporting the implant. Specifically, the method comprising the step of applying to a peri-implant bone displaying crestal resorption a 5 pharmaceutical composition comprising biocompatible bone augmentation material coated with a matrix composition which provides local controlled and prolonged release of at least one pharmaceutically active agent at the bone loss site.

The present invention relates to pharmaceutical compositions and methods for the treatment of peri-implant diseases, in particular peri-implant disease characterized by the destruction of the crest of the alveolar bone supporting the implant. Specifically, the method comprising the step of applying to a peri-implant bone displaying crestal resorption a 5 pharmaceutical composition comprising biocompatible bone augmentation material coated with a matrix composition which provides local controlled and prolonged release of at least one pharmaceutically active agent at the bone loss site.